NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1720387776|ref|XP_030105143|]
View 

cell cycle control protein 50C isoform X3 [Mus musculus]

Protein Classification

CDC50/LEM3 family protein( domain architecture ID 10506127)

CDC50/LEM3 (ligand-effect modulator 3) family protein is a membrane protein, such as cell cycle control protein 50 (CDC50) and plant ALA-interacting subunits

Gene Ontology:  GO:0016020

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
CDC50 pfam03381
LEM3 (ligand-effect modulator 3) family / CDC50 family; Members of this family have been ...
5-289 1.65e-110

LEM3 (ligand-effect modulator 3) family / CDC50 family; Members of this family have been predicted to contain transmembrane helices. The family member LEM3 is a ligand-effect modulator, mutation of which increases glucocorticoid receptor activity in response to dexamethasone and also confers increased activity on other intracellular receptors including the progesterone, oestrogen and mineralocorticoid receptors. LEM3 is thought to affect a downstream step in the glucocorticoid receptor pathway. Factors that modulate ligand responsiveness are likely to contribute to the context-specific actions of the glucocorticoid receptor in mammalian cells. The products of genes YNR048w, YNL323w and YCR094w (CDC50) show redundancy of function and are involved in regulation of transcription via CDC39. CDC39 (also known as NOT1) is normally a negative regulator of transcription either by affecting the general RNA polymerase II machinery or by altering chromatin structure. One function of CDC39 is to block activation of the mating response pathway in the absence of pheromone, and mutation causes arrest in G1 by activation of the pathway. It may be that the cold-sensitive arrest in G1 noticed in CDC50 mutants may be due to inactivation of CDC39. The effects of LEM3 on glucocorticoid receptor activity may also be due to effects on transcription via CDC39.


:

Pssm-ID: 460906  Cd Length: 292  Bit Score: 321.47  E-value: 1.65e-110
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776   5 CLSTNTSNLEHQINYTKTCANCA-----QLRENSSNFDKACNCSLPFYLPEKMEGDVYMYYKLYGFYQNLYQYILSRSNS 79
Cdd:pfam03381   1 LLYASNNVQEIVIDYTDDCATLAptdnfNPIDYIQNSNETKTCTIQFTIPKDMKGPVYLYYKLTNFYQNHRRYVKSRDDD 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776  80 QLVGK---DIWDTTNCDPFQVSH---NDTPIIPCGAIANSIFNDTITLSYNLNSSTQI----EVPMLKSGLTWWTDKYVK 149
Cdd:pfam03381  81 QLKGKavsALLSGSSCKPLRYNGardDGKPIYPCGLIANSMFNDTFTLYNNSSPLLLNvgtsTYPLTKKGIAWPSDKEHK 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776 150 FRNPRSSNFTSTfagsSKPLHWAKPIYELDLDDPGNNGFLNEDFIVWMRTAAFPTFKKLYRRLKRVhafaEGLPAGNYSL 229
Cdd:pfam03381 161 FKNPTKYNASDI----VPPPNWQKRYPNGYTEDNIPNLSENEDFIVWMRTAALPTFRKLYRRINDT----DGLPAGTYTI 232
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776 230 SISYNFPVTMFQGEKSIVLSTLTWIGGGGLFLGLTYTVTGALTLLASFAILTIHLMLKRS 289
Cdd:pfam03381 233 DIGYNYPVTSFGGTKSIVLSTTSWIGGKNPFLGIAYLVVGGICLLLGIVFLIIHLIKPRK 292
 
Name Accession Description Interval E-value
CDC50 pfam03381
LEM3 (ligand-effect modulator 3) family / CDC50 family; Members of this family have been ...
5-289 1.65e-110

LEM3 (ligand-effect modulator 3) family / CDC50 family; Members of this family have been predicted to contain transmembrane helices. The family member LEM3 is a ligand-effect modulator, mutation of which increases glucocorticoid receptor activity in response to dexamethasone and also confers increased activity on other intracellular receptors including the progesterone, oestrogen and mineralocorticoid receptors. LEM3 is thought to affect a downstream step in the glucocorticoid receptor pathway. Factors that modulate ligand responsiveness are likely to contribute to the context-specific actions of the glucocorticoid receptor in mammalian cells. The products of genes YNR048w, YNL323w and YCR094w (CDC50) show redundancy of function and are involved in regulation of transcription via CDC39. CDC39 (also known as NOT1) is normally a negative regulator of transcription either by affecting the general RNA polymerase II machinery or by altering chromatin structure. One function of CDC39 is to block activation of the mating response pathway in the absence of pheromone, and mutation causes arrest in G1 by activation of the pathway. It may be that the cold-sensitive arrest in G1 noticed in CDC50 mutants may be due to inactivation of CDC39. The effects of LEM3 on glucocorticoid receptor activity may also be due to effects on transcription via CDC39.


Pssm-ID: 460906  Cd Length: 292  Bit Score: 321.47  E-value: 1.65e-110
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776   5 CLSTNTSNLEHQINYTKTCANCA-----QLRENSSNFDKACNCSLPFYLPEKMEGDVYMYYKLYGFYQNLYQYILSRSNS 79
Cdd:pfam03381   1 LLYASNNVQEIVIDYTDDCATLAptdnfNPIDYIQNSNETKTCTIQFTIPKDMKGPVYLYYKLTNFYQNHRRYVKSRDDD 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776  80 QLVGK---DIWDTTNCDPFQVSH---NDTPIIPCGAIANSIFNDTITLSYNLNSSTQI----EVPMLKSGLTWWTDKYVK 149
Cdd:pfam03381  81 QLKGKavsALLSGSSCKPLRYNGardDGKPIYPCGLIANSMFNDTFTLYNNSSPLLLNvgtsTYPLTKKGIAWPSDKEHK 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776 150 FRNPRSSNFTSTfagsSKPLHWAKPIYELDLDDPGNNGFLNEDFIVWMRTAAFPTFKKLYRRLKRVhafaEGLPAGNYSL 229
Cdd:pfam03381 161 FKNPTKYNASDI----VPPPNWQKRYPNGYTEDNIPNLSENEDFIVWMRTAALPTFRKLYRRINDT----DGLPAGTYTI 232
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776 230 SISYNFPVTMFQGEKSIVLSTLTWIGGGGLFLGLTYTVTGALTLLASFAILTIHLMLKRS 289
Cdd:pfam03381 233 DIGYNYPVTSFGGTKSIVLSTTSWIGGKNPFLGIAYLVVGGICLLLGIVFLIIHLIKPRK 292
CDC50 COG5035
Cell cycle control protein [Cell division and chromosome partitioning / Transcription / Signal ...
5-293 1.04e-39

Cell cycle control protein [Cell division and chromosome partitioning / Transcription / Signal transduction mechanisms];


Pssm-ID: 227368  Cd Length: 372  Bit Score: 142.32  E-value: 1.04e-39
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776   5 CLSTNTSNLEH------QINYTKTCANCAQLRENSSNFDKACNCSLPFYLPEKMEGDVYMYYKLYGFYQNLYQYILSRSN 78
Cdd:COG5035    80 CMTLASDEFSDipseyiQFHFKKKVNVLPQWRFSTDEEDDFQKCQIRFTVPSDMKKPVFIYYRLTNFYQNHRRYVKSFDE 159
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776  79 SQLVGKDI-WDT--TNCDPFQvSHNDTPIIPCGAIANSIFNDT--ITLSYNLNSStqiEVPMLKSGLTWWTDKYvKFRNP 153
Cdd:COG5035   160 DQLRGEALkSDDlkSNCKPLS-YNEDKIIYPCGLIANSMFNDTfsSLLTGIEDTS---NYNLTTKGIAWESDRH-RYKKT 234
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776 154 rSSNFTSTFAgsskPLHWAKPIYELDLDDPGNNGFLNEDFIVWMRTAAFPTFKKLYRRLKrvhafAEGLPAGNYSLSISY 233
Cdd:COG5035   235 -KYNASDIVP----PPNWAKMYPDGYTDDNIPDLSTWEEFQNWMRTAAFPKFSKLAMRNV-----NDVLPPGTYQLNITL 304
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1720387776 234 NFPVTMFQGEKSIVLSTLTWIGGGGLFLGLTYTVTGALTLLASFAILTIHLMLKR-----SKLNF 293
Cdd:COG5035   305 NFPVLEFNGTKSIVLTTNSVIGGKNYFLGIVYLIVGGICALLGLIFLIKWLFKPRkmadhSYLNW 369
 
Name Accession Description Interval E-value
CDC50 pfam03381
LEM3 (ligand-effect modulator 3) family / CDC50 family; Members of this family have been ...
5-289 1.65e-110

LEM3 (ligand-effect modulator 3) family / CDC50 family; Members of this family have been predicted to contain transmembrane helices. The family member LEM3 is a ligand-effect modulator, mutation of which increases glucocorticoid receptor activity in response to dexamethasone and also confers increased activity on other intracellular receptors including the progesterone, oestrogen and mineralocorticoid receptors. LEM3 is thought to affect a downstream step in the glucocorticoid receptor pathway. Factors that modulate ligand responsiveness are likely to contribute to the context-specific actions of the glucocorticoid receptor in mammalian cells. The products of genes YNR048w, YNL323w and YCR094w (CDC50) show redundancy of function and are involved in regulation of transcription via CDC39. CDC39 (also known as NOT1) is normally a negative regulator of transcription either by affecting the general RNA polymerase II machinery or by altering chromatin structure. One function of CDC39 is to block activation of the mating response pathway in the absence of pheromone, and mutation causes arrest in G1 by activation of the pathway. It may be that the cold-sensitive arrest in G1 noticed in CDC50 mutants may be due to inactivation of CDC39. The effects of LEM3 on glucocorticoid receptor activity may also be due to effects on transcription via CDC39.


Pssm-ID: 460906  Cd Length: 292  Bit Score: 321.47  E-value: 1.65e-110
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776   5 CLSTNTSNLEHQINYTKTCANCA-----QLRENSSNFDKACNCSLPFYLPEKMEGDVYMYYKLYGFYQNLYQYILSRSNS 79
Cdd:pfam03381   1 LLYASNNVQEIVIDYTDDCATLAptdnfNPIDYIQNSNETKTCTIQFTIPKDMKGPVYLYYKLTNFYQNHRRYVKSRDDD 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776  80 QLVGK---DIWDTTNCDPFQVSH---NDTPIIPCGAIANSIFNDTITLSYNLNSSTQI----EVPMLKSGLTWWTDKYVK 149
Cdd:pfam03381  81 QLKGKavsALLSGSSCKPLRYNGardDGKPIYPCGLIANSMFNDTFTLYNNSSPLLLNvgtsTYPLTKKGIAWPSDKEHK 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776 150 FRNPRSSNFTSTfagsSKPLHWAKPIYELDLDDPGNNGFLNEDFIVWMRTAAFPTFKKLYRRLKRVhafaEGLPAGNYSL 229
Cdd:pfam03381 161 FKNPTKYNASDI----VPPPNWQKRYPNGYTEDNIPNLSENEDFIVWMRTAALPTFRKLYRRINDT----DGLPAGTYTI 232
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776 230 SISYNFPVTMFQGEKSIVLSTLTWIGGGGLFLGLTYTVTGALTLLASFAILTIHLMLKRS 289
Cdd:pfam03381 233 DIGYNYPVTSFGGTKSIVLSTTSWIGGKNPFLGIAYLVVGGICLLLGIVFLIIHLIKPRK 292
CDC50 COG5035
Cell cycle control protein [Cell division and chromosome partitioning / Transcription / Signal ...
5-293 1.04e-39

Cell cycle control protein [Cell division and chromosome partitioning / Transcription / Signal transduction mechanisms];


Pssm-ID: 227368  Cd Length: 372  Bit Score: 142.32  E-value: 1.04e-39
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776   5 CLSTNTSNLEH------QINYTKTCANCAQLRENSSNFDKACNCSLPFYLPEKMEGDVYMYYKLYGFYQNLYQYILSRSN 78
Cdd:COG5035    80 CMTLASDEFSDipseyiQFHFKKKVNVLPQWRFSTDEEDDFQKCQIRFTVPSDMKKPVFIYYRLTNFYQNHRRYVKSFDE 159
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776  79 SQLVGKDI-WDT--TNCDPFQvSHNDTPIIPCGAIANSIFNDT--ITLSYNLNSStqiEVPMLKSGLTWWTDKYvKFRNP 153
Cdd:COG5035   160 DQLRGEALkSDDlkSNCKPLS-YNEDKIIYPCGLIANSMFNDTfsSLLTGIEDTS---NYNLTTKGIAWESDRH-RYKKT 234
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1720387776 154 rSSNFTSTFAgsskPLHWAKPIYELDLDDPGNNGFLNEDFIVWMRTAAFPTFKKLYRRLKrvhafAEGLPAGNYSLSISY 233
Cdd:COG5035   235 -KYNASDIVP----PPNWAKMYPDGYTDDNIPDLSTWEEFQNWMRTAAFPKFSKLAMRNV-----NDVLPPGTYQLNITL 304
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1720387776 234 NFPVTMFQGEKSIVLSTLTWIGGGGLFLGLTYTVTGALTLLASFAILTIHLMLKR-----SKLNF 293
Cdd:COG5035   305 NFPVLEFNGTKSIVLTTNSVIGGKNYFLGIVYLIVGGICALLGLIFLIKWLFKPRkmadhSYLNW 369
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH